Los Angeles Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$950K Sell
246,644
-272,203
-52% -$993K ﹤0.01% 762
2026
Q1
$2.05M Buy
518,847
+518,008
+61,741% +$2.61M 0.01% 499
2025
Q4
$6.21K Buy
+839
New +$5.88K ﹤0.01% 2233
2025
Q2
– Sell
-104,818
Closed -$797K – 1415
2025
Q1
$797K Sell
104,818
-37,688
-26% -$315K ﹤0.01% 626
2024
Q4
$1.37M Hold
142,506
– – 0.01% 538
2024
Q3
$842K Hold
142,506
– – ﹤0.01% 696
2024
Q2
$988K Buy
+142,506
New +$1M ﹤0.01% 653

Other funds holding MDXG

Los Angeles Capital Management's MDXG Position: Q2 2026 in Review

Los Angeles Capital Management reduced its MiMedx Group (MDXG) stake by 52% in Q2 2026, selling an estimated $993K and leaving 246,644 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Los Angeles Capital Management first reported a position in MDXG in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.05M in Q1 2026. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Los Angeles Capital Management held 246,644 shares of MiMedx Group worth $950K as of Q2 2026.
  • Los Angeles Capital Management sold 272,203 MiMedx Group shares in Q2 2026, an estimated $993K.
  • MiMedx Group made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #762 holding.
  • Los Angeles Capital Management first reported a position in MiMedx Group in Q2 2024 and has held it in 7 quarters since.
  • Los Angeles Capital Management's MiMedx Group position peaked at $2.05M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.